HIV 1 transcription: Tat/novel cofactors/Mechanisms

HIV 1 转录:Tat/新型辅助因子/机制

基本信息

  • 批准号:
    6892475
  • 负责人:
  • 金额:
    $ 21.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2008-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The HIV-1-encoded Tat protein is a potent transcriptional activator that is essential for viral replication. The long-term objective of this proposal is to gain a better understanding of the control of HIV-1 gene expression by Tat and cellular factors at the molecular level. This study will focus on a novel RNA Pol II complex (Tat- SF) that efficiently mediates Tat-enhanced transcription (Tat function). Tat-SF contains P-TEFb, Spt5/Spt4, and Tat-SF1 and novel polypeptides, but none of the yeast coactivator SRB/MED-like proteins found associated with RNA Pol II holoenzyme. Notably, these Tat-SF cofactors can jointly complement the transcription initiation competent RNA Pol II holoenzyme for potent transcription elongation, reinitiation, and Tat transactivation, indicating that Tat-SF contains critical transcription factors. The mechanisms by which Tat-SF and RNA Pol II holoenzyme collectively mediate potent Tat-enhanced HIV-1 transcription are poorly understood. This proposal has three specific aims. The first will determine and compare the polypeptide composition of Tat-SF and Tat-SF cofactors derived from HeLa cytoplasm, nuclear extract, and nuclear pellet (chromatin). The second aim will examine the mechanisms by which Tat-SF cofactors mediate potent Tat-enhanced HIV-1 transcription. These studies will provide insights into synergisms of Tat-SF cofactors within themselves and with other transcription factors and protein modifications (e.g. phosphorylation, acetylation, methylation) for potent Tat activation. The third aim will specifically study the interplay of Tat-SF and the SRB/MED complex for efficient general transcription reinitiation and elongation. These experiments will include the detailed characterization of a potential SRB/MED complex-containing scaffold formed on the HIV- 1 promoter that could be utilized by Tat-SF for efficient transcription. The effects of Tat on Tat-SF- and RNA Pol II holoenzyme-mediated transcription elongation and re-initiation will also be examined. Collectively, these studies will identify novel factors and mechanisms that are important for single and multiple round of HIV-1 transcription. They will also establish a unique well-defined in vitro system for future elaboration of the link between HIV-1 transcription elongation and mRNA processing either on naked or chromatin DNA templates. Together, understanding Tat-enhanced HIV-1 transcription at the molecular level will be instrumental for future therapeutic antiviral strategies to block viral replication.
描述(申请人提供):HIV-1编码的TAT蛋白是一种有效的转录激活剂,对病毒复制至关重要。这项建议的长期目标是在分子水平上更好地了解TAT和细胞因子对HIV-1基因表达的控制。本研究将集中于一种新的RNA POLII复合体(TAT-SF),它能有效地介导TAT增强的转录(TAT功能)。TAT-SF含有P-TEFb、Spt5/Spt4、TAT-SF1和新的多肽,但没有发现与RNA PolII全酶相关的酵母共激活因子SRB/MED样蛋白。值得注意的是,这些TAT-SF辅助因子可以共同补充转录起始活性RNA POL II全酶,从而有效地转录延伸、重新启动和TAT反式激活,表明TAT-SF含有关键的转录因子。TAT-SF和RNA POLII全酶共同介导TAT增强的HIV-1转录的机制尚不清楚。这项提议有三个具体目标。首先将测定和比较来源于HeLa细胞质、核提取液和核小球(染色质)的TAT-SF和TAT-SF辅助因子的多肽组成。第二个目标将研究TAT-SF辅助因子介导TAT增强的HIV-1转录的机制。这些研究将为深入了解TAT-SF辅助因子本身以及与其他转录因子和蛋白质修饰(如磷酸化、乙酰化、甲基化)之间的协同作用而有效地激活TAT。第三个目标将专门研究TAT-SF和SRB/MED复合体之间的相互作用,以实现有效的一般转录重新启动和延伸。这些实验将包括对在HIV-1启动子上形成的潜在的含有SRB/MED复合体的支架的详细表征,TAT-SF可以利用该支架进行高效转录。TAT对TAT-SF-和RNA POLII全酶介导的转录延长和重新启动的影响也将被检测。总的来说,这些研究将确定对HIV-1单轮和多轮转录至关重要的新因素和新机制。他们还将建立一个独特的、定义明确的体外系统,用于未来详细阐述HIV-1转录延伸和在裸露或染色质DNA模板上的mRNA处理之间的联系。总之,在分子水平上了解TAT增强的HIV-1转录将有助于未来阻止病毒复制的治疗抗病毒策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CAMILO A PARADA其他文献

CAMILO A PARADA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CAMILO A PARADA', 18)}}的其他基金

HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
  • 批准号:
    7008196
  • 财政年份:
    2005
  • 资助金额:
    $ 21.77万
  • 项目类别:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
  • 批准号:
    7102120
  • 财政年份:
    2005
  • 资助金额:
    $ 21.77万
  • 项目类别:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 转录:Tat/新型辅助因子/机制
  • 批准号:
    7174181
  • 财政年份:
    2005
  • 资助金额:
    $ 21.77万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 21.77万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 21.77万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 21.77万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 21.77万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了